Live Breaking News & Updates on Analyst Recommendations For Jazz Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $200.75 Consensus Price Target from Brokerages

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) has received a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the […] ....

Neenam Patil , Insider Activity At Jazz Pharmaceuticals , Power Corp , Goldman Sachs Group , Toroso Investments , Analyst Recommendations For Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Securities Exchange Commission , Jazz Pharmaceuticals , Macquarie Group Ltd , Needham Company , Royal Bank , Jazz Pharmaceuticals Stock Performance , Ameriprise Financial Inc , Jazz Pharmaceuticals Plc , Institutional Investors Weigh In On Jazz Pharmaceuticals , Get Rating , Marketbeat Ratings , Exchange Commission , Teachers Pension Plan Board , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $200.75 Consensus Price Target from Analysts

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) has been given a consensus recommendation of “Buy” by the nine analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the […] ....

Neenam Patil , Jazz Pharmaceuticals Stock Performance , Jazz Pharmaceuticals Plc , Institutional Investors Weigh In On Jazz Pharmaceuticals , Envestnet Asset Management Inc , Royal Bank , Jazz Pharmaceuticals Company Profile , Baupost Group , Analyst Recommendations For Jazz Pharmaceuticals , Securities Exchange Commission , News Ratings For Jazz Pharmaceuticals Daily , Needham Company , Pacer Advisors Inc , Goldman Sachs Group , Jazz Pharmaceuticals , Get Rating , Exchange Commission , Asset Management , Partners Management , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) in a research note published on Thursday morning. The firm issued a strong-buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts have also recently issued reports on JAZZ. Royal Bank of Canada decreased their price objective on shares […] ....

Patricia Carr , Kim Sablich , Royal Bank , Insider Transactions At Jazz Pharmaceuticals , Jazz Pharmaceuticals Company Profile , Analyst Recommendations For Jazz Pharmaceuticals , Institutional Investors Weigh In On Jazz Pharmaceuticals , Jazz Pharmaceuticals , Prudential Financial Inc , Jazz Pharmaceuticals Plc , Pacer Advisors Inc , Baupost Group , Envestnet Asset Management Inc , Jazz Pharmaceuticals Stock Performance , News Ratings For Jazz Pharmaceuticals Daily , Goldman Sachs Group , Needham Company , Get Rating , Asset Management , Partners Management , Prudential Financial , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Initiated Coverage , Stocknews Com ,

Qurate Retail, Inc. Announces Quarterly Dividend of $2.00 (NASDAQ:QRTEP)

StockNews.com began coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) in a research report released on Thursday. The firm issued a strong-buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently issued reports on JAZZ. The Goldman Sachs Group boosted their price target on Jazz Pharmaceuticals from […] ....

Finbar Larkin , Patricia Carr , Royal Bank , Aviva Plc , Analyst Recommendations For Jazz Pharmaceuticals , Institutional Investors Weigh In On Jazz Pharmaceuticals , Jazz Pharmaceuticals , Securities Exchange Commission , Jazz Pharmaceuticals Plc , Vanguard Group Inc , Us Bancorp , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Stock , Advisor Group , Needham Company , Goldman Sachs Group , Get Rating , Exchange Commission , Asset Management Gmbh , Vanguard Group , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) PT Raised to $212.00

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) had its target price increased by Needham & Company LLC from $205.00 to $212.00 in a research note released on Thursday, The Fly reports. JAZZ has been the subject of a number of other research reports. StockNews.com raised Jazz Pharmaceuticals from a buy rating to a strong-buy rating in […] ....

Finbar Larkin , Patricia Carr , Needham Company , Goldman Sachs Group , Analyst Recommendations For Jazz Pharmaceuticals , Us Bancorp , Jazz Pharmaceuticals Trading Down , News Ratings For Jazz Pharmaceuticals Daily , Advisor Group , Aviva Plc , Jazz Pharmaceuticals Plc , Hedge Funds Weigh In On Jazz Pharmaceuticals , Vanguard Group Inc , Jazz Pharmaceuticals , Get Rating , Pharmaceuticals Trading Down , Asset Management Gmbh , Vanguard Group , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Boost Price Target , Needham Company Llc ,